Los puntos clave no están disponibles para este artículo en este momento.
The addition of oxaliplatin to capecitabine improves DFS in patients with stage III colon cancer. XELOX is an additional adjuvant treatment option for these patients.
Haller et al. (Tue,) studied this question.